
       Dr. Philip G. Colin, a chemical engineer who developed industrial processes for many drugs, died of a heart attack on Oct. 5 at his home in San Diego. He was 86 years old.
        Dr. Philip G. Colin, a chemical engineer who developed industrial processes for many drugs, died of a heart attack on Oct. 5 at his home in San Diego. He was 86 years old.
        Dr. Colin helped develop processes for synthetic vitamins, penicillin, cortisone and other drugs. He started working for Merck & Company and its affiliates in 1941 and from 1964 to 1967, was vice president of Merck, Sharp & Dohme International and managing director of its subsidiary in Bermuda.
        The Japanese Government honored him in 1950 for his guidance in developing streptomycin factories. The drug was urgently needed to combat a tuberculosis epidemic.
        Before joining Merck, Dr. Colin had been a research associate at the Rockefeller Institute and had headed laboratories at the Tidewater Oil Company.
        Dr. Colin was born in Baltimore. He received a degree in chemical and electrical engineering and a doctorate in chemistry from the University of Washington.
        Surviving are his wife, the former Alice von Pressentin; two daughters, Diane Culver of Winchester, Mass., and Carol Wright of Guilford, Conn.; five grandchildren, and a great-granddaughter.
      